SOMERSET, N.J., Oct. 03, 2023 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDP, CCLDO), a leader in healthcare technology services for medical practices and health systems nationwide, today announced its medSR division recently completed the successful implementation of MEDITECH Expanse, a comprehensive electronic health record (EHR) system, for Doctors Hospital Health System.
Situated in the heart of the Caribbean, Doctors Hospital stands as the Bahama region's premier privately owned acute care healthcare facility. Focused on preserving the continuity of patient care and safeguarding data integrity, Doctors Hospital made the strategic decision to convert their existing patient and financial data. Given their island location and the looming threat of hurricanes, they sought a robust system that could ensure data resilience even in the face of hardware damage.
Following a meticulous evaluation of various EHR systems and implementation partners, Doctors Hospital selected CareCloud’s medSR to implement MEDITECH Expanse, recognizing its capacity to address their unique needs and requirements. To steer the complexities of the implementation process, Doctors Hospital chose medSR, whose expertise and track record in healthcare information technology (IT) implementation were instrumental in the project's success.
Samantha Lockhart, assistant vice president at Doctors Hospital, remarked, "From the very beginning, medSR's expertise was evident. Their team's depth of knowledge and experience was incredible, and their ability to transparently meet us at our point of need gave us the confidence we had found our partner."
The successful implementation of the new EHR system has ushered in enhancements in patient care, data management, and disaster recovery capabilities for Doctors Hospital. It's a resounding success story, further solidifying Doctors Hospital's commitment to excellence in healthcare.
medSR is a leading provider of healthcare IT consulting and implementation services, boasting three decades of experience in helping healthcare organizations of all sizes successfully implement and optimize their EHR systems. medSR's team of knowledgable professionals possesses an in-depth understanding of the unique challenges and opportunities facing healthcare organizations in today's complex environment.
medSR offers a comprehensive suite of capabilities to empower healthcare organizations to achieve their clinical and financial goals:
For more information on how medSR can contribute to the transformation of your healthcare organization, please visit medSR.com.
About CareCloud
CareCloud (Nasdaq: CCLD, CCLDP, CCLDO) brings disciplined innovation to the business of healthcare. Our suite of technology-enabled solutions helps clients increase financial and operational performance, streamline clinical workflows and improve the patient experience. More than 40,000 providers count on CareCloud to help them improve patient care while reducing administrative burdens and operating costs. Learn more about our products and services, including revenue cycle management (RCM), practice management (PM), electronic health records (EHR), business intelligence, patient experience management (PXM) and digital health, at www.carecloud.com.
Follow CareCloud on LinkedIn, Twitter and Facebook.
Company Contact:
Bill Korn
Chief Strategy Officer
CareCloud
This email address is being protected from spambots. You need JavaScript enabled to view it.
Investor Contact:
Asher Dewhurst
ICR Westwicke
This email address is being protected from spambots. You need JavaScript enabled to view it.
Media Inquiries:
Alexis Feinberg
ICR Westwicke
This email address is being protected from spambots. You need JavaScript enabled to view it.
Last Trade: | US$1.25 |
Daily Change: | -0.01 -0.79 |
Daily Volume: | 645,400 |
Market Cap: | US$20.320M |
April 07, 2025 April 02, 2025 March 26, 2025 March 13, 2025 January 28, 2025 |
Immix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...
CLICK TO LEARN MOREClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...
CLICK TO LEARN MOREEnd of content
No more pages to load